finanzen.net

813245 ORBUS PHARMA

Seite 1 von 1
neuester Beitrag: 31.05.05 12:01
eröffnet am: 22.01.04 14:26 von: miwi666 Anzahl Beiträge: 5
neuester Beitrag: 31.05.05 12:01 von: HiGhLiFE Leser gesamt: 1832
davon Heute: 0
bewertet mit 0 Sternen

22.01.04 14:26

182 Postings, 6038 Tage miwi666813245 ORBUS PHARMA

Was haltet ihr von dem Wert?? Könnte ein interessanter Zock sein oder???  

17.02.04 11:03

10 Postings, 6125 Tage matzisnOrbus

ja ich denke auch. Wurde schon mal im Oberbayrischen Börsenbrief empfohlen. Der Chart sie im Moment auch gut aus.  

31.05.05 11:32

2862 Postings, 6127 Tage HiGhLiFEkommt leben rein +29% gestern

bereits 0,94 $CAN, in Fra derzeit bei 0,55?  

31.05.05 11:34

2862 Postings, 6127 Tage HiGhLiFEab juni ins öl-geschäft

bei einer derzeitigen MK von knapp 16 Mio?, könnte sich hier ein Riesenaufwärtspotential bieten, da neben der Pharmasparte der Ölsektor für ordentlich Umsatz sorgen kann.







Orbus Pharma Inc. Announces a Proposed Plan of Arrangement

Friday May 20, 7:50 pm ET


TORONTO, ONTARIO--(CCNMatthews - May 20, 2005) - Orbus Pharma Inc. ("Orbus") (TSX:ORB - News; FWB:OBP) announced today that at a special meeting of shareholders on June 20, 2005, it will be seeking approval of a proposed Plan of Arrangement (the "Arrangement") and participation in a proposed Plan of Arrangement (the "Chamaelo Arrangement") by Chamaelo Energy Inc.
ADVERTISEMENT


Pursuant to the Arrangement, the business, assets and capital of Orbus will be restructured in order for it to be utilized as an oil and gas exploration and development company under the name Chamaelo Exploration Ltd.

A new corporation ("Newco") will acquire all of the assets and related liabilities of Orbus and have the same issued capital structure as Orbus. Newco will continue the existing business of generic drug development, manufacturing and pharmaceutical trading currently being operated by Orbus.

Chamaelo Exploration Ltd., as Orbus will be known following completion of the Arrangement, will have a new board of directors, newly acquired oil and gas assets and additional working capital and will focus on building a successful oil and natural gas exploration and development company.

Subsequent to the effective date of the Arrangement and after the participation of Orbus in the Chamaelo Arrangement, holders of Orbus common shares ("Shareholders") will hold 100% of Newco, which will hold all of the assets and business and related liabilities formerly held by Orbus, and approximately 3.03% of Chamaelo Exploration Ltd. common shares. Holders of Convertible Debentures and Warrants of Orbus will hold approximately 1.43% of Chamaelo Exploration Ltd. (which will be non-voting shares). The exact percentage participation of securityholders of Chamaelo Exploration Ltd. will be determined on or about May 31, 2005.

Under the Chamaelo Arrangement, Chamaelo Exploration Ltd. will receive the oil and natural gas assets, which comprise certain of Chamaelo Energy Inc.'s producing assets in west-central Alberta, the Peace River Arch area of Alberta and northeast British Columbia and undeveloped lands, most of which are located in west-central Alberta and northeast British Columbia. Chamaelo Exploration Ltd. is expected to have average production of approximately 1,050 barrels of oil equivalent per day (65% natural gas) on closing of the Chamaelo Arrangement. The assets also contain approximately 112,000 (60,000 net) acres of undeveloped land. In addition, Orbus will have the option to farm-in on approximately 41,000 gross acres of option land in west-central Alberta on standard industry terms.

The management team of Chamaelo Exploration Ltd. will be led by Robert Zakresky, as President and Chief Executive Officer, Richard Sereda as Vice President Exploration, Weldon Dueck as Vice President Business Development and Nolan Chicoine as Vice President Finance and Chief Financial Officer. In addition to Mr. Zakresky, the board of directors will include Larry Moeller, Donald Cowie and Daryl Gilbert.

Participation by Orbus in the Chamaelo Arrangement is subject to various conditions including due diligence. The Board of Directors of Orbus may determine to proceed with the Arrangement in any event.

Newco intends to operate under the name Orbus Pharma Inc. and apply for a substitutional listing of its common shares on the Toronto Stock Exchange. The management team will continue to be led by Jeffrey W. Renwick, as President and Chief Executive Officer, Denis Arsenault, C.A. as Vice President Finance and Chief Financial Officer and the current Board of Directors.

An information circular will be provided to all shareholders before the end of May 2005 that will outline the details of the proposed transaction and the benefits
 

31.05.05 12:01

2862 Postings, 6127 Tage HiGhLiFEheute Angriff auf die Dollarmarke o. T.

   Antwort einfügen - nach oben

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Deutsche Bank AG514000
Scout24 AGA12DM8
Wirecard AG747206
NEL ASAA0B733
Lufthansa AG823212
Daimler AG710000
Airbus SE (ex EADS)938914
TUITUAG00
Allianz840400
Carnival Corp & plc paired120100
ITM Power plcA0B57L
BASFBASF11
CommerzbankCBK100
Plug Power Inc.A1JA81
BayerBAY001